- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Breast Cancer in Australia
Total 2008 results
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Medical University of ViennaCompletedDepressive; Episode, Major | Recurrent Depressive Disorder, Current Episode Moderate | Recurrent Depressive Disorder, Current Episode MildAustria
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...CompletedMetastatic Breast CancerAustralia
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
PharmAbcineMerck Sharp & Dohme LLCRecruitingMetastatic Triple-Negative Breast CancerAustralia
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Australian & New Zealand Children's Haematology...The Hospital for Sick Children; Kazia Therapeutics Limited; Day One Biopharmaceuticals... and other collaboratorsNot yet recruitingChildhood Cancer | Refractory Cancer | Recurrent Cancer | Childhood Solid Tumor | Childhood Brain TumorAustralia, Canada
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic Breast CancerFrance, Austria, Belgium, Australia, Italy
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
AirXpanders, Inc.CompletedBreast Cancer | Breast ReconstructionAustralia
-
AirXpanders, Inc.CompletedBreast Cancer | Breast Reconstruction | MastectomyAustralia
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
PharmAbcineActive, not recruitingRecurrent GlioblastomaAustralia
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
Medical University of ViennaActive, not recruitingProstate Cancer RecurrentAustria
-
St Vincent's Hospital, SydneyRecruitingTriple Negative Breast CancerAustralia
-
Spago Nanomedical ABRecruitingSolid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid TumorAustralia
-
Peter MacCallum Cancer Centre, AustraliaMelbourne Health; M.D. Anderson Cancer Center; The AlfredCompletedCancer, Breast | Cancer Colorectal | Cancer, Lung | Cancer Prostate | Cancer Melanoma Skin | Cancer, OtherAustralia
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
AkesoAkesobio Australia Pty LtdCompletedMetastatic Cervical Cancer | Recurrent Cervical CancerUnited States, Australia, New Zealand
-
St Vincent's HospitalRecruitingHormone Receptor Positive Tumor | Early-stage Breast CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedMalignant Rectal Neoplasm | Recurrent TumorAustralia
-
Contact Asia PacificUnknown
-
Genor Biopharma Co., Ltd.Completed
-
Curtin UniversityActive, not recruiting
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Olema Pharmaceuticals, Inc.PfizerRecruiting
-
Abbott ProductsCompletedRecurrent MiscarriageAustria, Poland
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Hoffmann-La RocheCompleted
-
Medical University of GrazCompletedRecurrent Urinary Tract InfectionAustria
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
St Vincent's Hospital, SydneyNovartisRecruitingBreast CancerAustralia
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
ETOP IBCSG Partners FoundationCompleted
-
St George Hospital, AustraliaAstraZenecaUnknown